It is important to realize that our groups and others have previously demonstrated that LNK might play an alternate role in solid tumor cells in hematopoietic and lymphoid cancers [36, 37], while it showed few effects on proliferation and migration in some solid tumor cell lines [35], and regarded as a negative inhibitor in tumor [38]. Here, SH2B3 is linked to lymphoma.